Consistently, AURKB was found to be aberrantly activated in cancer types, including multiple myeloma, colorectal, prostate, and pancreatic cancers33, and associated with a poor prognosis of cancer patients34. The gene discussed is AURKB; the disease is plasma cell myeloma.